13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 90 holding rows worth $349,550,312.
- Accession
- 0001420506-23-000635
- Filer
- CIK 1816307
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 90 entries on the cover page, a total value of $349,550,312 stated on the cover page (in dollars after the unit check, H1), rows summing to $349,550,312 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSILVERARC CAPITAL, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 172,400 | $18,964,000 | dollars as filed | put |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 49,898 | $14,482,895 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,707,370 | $14,034,581 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 2,230,000 | $11,819,000 | dollars as filed | |
| Viewra, Inc | 92672L107 | COM | 2,405,360 | $10,776,013 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 253,655 | $10,001,617 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 172,100 | $9,431,080 | dollars as filed | |
| ANAVEX LIFE SCIENCES CORP | 032797300 | COM NEW | 1,007,700 | $9,331,302 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 519,614 | $9,223,149 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 302,963 | $9,022,238 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 334,535 | $8,948,811 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 37,652 | $8,947,998 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 30,000 | $8,707,500 | dollars as filed | put |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 150,000 | $8,220,000 | dollars as filed | put |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 150,000 | $8,220,000 | dollars as filed | call |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 140,366 | $7,428,169 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,236,296 | $7,281,783 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 700,000 | $7,126,000 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,140,182 | $6,681,467 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 21,975 | $6,085,317 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 1,634,014 | $5,964,151 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 314,584 | $5,772,616 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 352,193 | $5,547,040 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 50,000 | $5,500,000 | dollars as filed | |
| CINCOR PHARMA INC | 17240Y109 | COM | 395,382 | $4,859,245 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 136,178 | $4,785,295 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 200,000 | $4,746,000 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 58,535 | $4,637,143 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 546,875 | $4,511,719 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 16,048 | $4,462,788 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 51,962 | $4,460,938 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 71,706 | $4,320,287 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 274,704 | $4,249,671 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 217,503 | $4,204,333 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 612,475 | $4,109,707 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 480,701 | $4,047,502 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 83,135 | $3,986,323 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 439,788 | $3,830,553 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 11,384 | $3,287,472 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 272,173 | $3,124,546 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 400,812 | $2,921,919 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 128,000 | $2,840,320 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 23,151 | $2,827,432 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 152,747 | $2,795,270 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 85,390 | $2,763,220 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 160,000 | $2,632,000 | dollars as filed | call |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 23,054 | $2,623,545 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 124,465 | $2,486,811 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 54,699 | $2,437,934 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 229,416 | $2,420,339 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 374,422 | $2,096,763 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 179,000 | $2,069,240 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 407,269 | $2,020,054 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 108,000 | $2,018,520 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 88,243 | $1,889,283 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 295,115 | $1,593,621 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 437,762 | $1,532,167 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 254,361 | $1,528,710 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 409,202 | $1,501,771 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 767,631 | $1,481,528 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 11,016 | $1,415,666 | dollars as filed | |
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 192,995 | $1,408,864 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 268,307 | $1,349,584 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 81,204 | $1,209,128 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 232,000 | $1,150,720 | dollars as filed | call |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 32,770 | $1,143,345 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 100,000 | $1,125,000 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 36,906 | $1,081,346 | dollars as filed | |
| ANAVEX LIFE SCIENCES CORP | 032797300 | COM NEW | 102,600 | $950,076 | dollars as filed | call |
| Veru Inc | 92536C103 | Common Stock | 175,000 | $924,000 | dollars as filed | put |
| CUE BIOPHARMA INC | 22978P106 | COM | 306,278 | $872,892 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 50,546 | $831,482 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 17,500 | $801,850 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 10,000 | $771,300 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 354,925 | $734,695 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 144,737 | $674,474 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 57,025 | $585,077 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 350,656 | $490,918 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 667,443 | $477,689 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 56,672 | $369,501 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 50,000 | $350,000 | dollars as filed | |
| BRAZE INC | 10576N102 | COM CL A | 10,000 | $272,800 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 98,409 | $234,213 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 10,000 | $226,700 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 100,000 | $217,000 | dollars as filed | |
| EVOGENE LTD | M4119S104 | SHS | 150,361 | $105,253 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,000 | $87,630 | dollars as filed | |
| ELOXX PHARMACEUTICALS INC NEW | 29014R202 | Com | 26,876 | $48,914 | dollars as filed | |
| FRESH TRACKS THERAPEUTICS INC | 10802T204 | Com | 10,000 | $15,000 | dollars as filed | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 49,990 | $4,499 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000635 | this filing | 2023-02-14 | acceptance time not in the bulk data set |